Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 01 MAY 2024

Market Intelligence Thought Leadership Award Winner

Hüskers Dü Privacy

Bass, Berry & Sims PLC
Explore more from Bass, Berry & Sims PLC

On April 17, Nebraska Governor Jim Pillen signed into law the Nebraska Data Privacy Act (the Act), making Nebraska the seventeenth state to enact general consumer data privacy legislation.

United StatesPrivacy
Alexandria Wood Davenport
Alexandria Wood Davenport
Ethan M. Riley
Ethan M. Riley
Roy Wyman
Roy Wyman

On April 17, Nebraska Governor Jim Pillen signed into law the Nebraska Data Privacy Act (the Act), making Nebraska the seventeenth state to enact general consumer data privacy legislation. The Act largely, but not completely, tracks the Texas Data Privacy and Security Act (TDPSA), which was signed into law last June. The Nebraska Act will take effect January 1, 2025.

Threshold Requirements and Exemptions

Whereas most prior state privacy laws have limited their applicability to legal entities that process the personal data of a large number of individuals or obtain significant revenue from the sale of personal data, the Act mirrors the TDPSA's applicability standards and applies to any person that meet the following criteria:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

SB 54 Is In Effect: What California’s New Packaging Law Means For Your Business

Although being challenged by an injunction filed on August 20, 2026, by a coalition of 17 states, California’s SB 54 Plastic Pollution Prevention and Packaging Producer Responsibility Act is now in effect, and companies that sell, distribute, import, or ship packaged products into California should be evaluating whether they have compliance obligations.
United StatesPrivacy
Wilson Elser Moskowitz Edelman & Dicker LLP
Wilson Elser Moskowitz Edelman & Dicker LLP
Article

California’s 2026 Legislative Session Wraps: A Wave Of Privacy And AI Bills Reaches The Governor, With Key Child Safety And AI Measures Signed Into Law

California's 2026 legislative session concluded with Governor Newsom signing several landmark privacy and AI bills into law, including comprehensive child safety measures, AI auditor oversight frameworks, and expanded data protection requirements. How will these new regulations reshape digital advertising, workplace AI deployment, and online platform obligations for businesses operating in California?
United StatesPrivacy
Kelley Drye & Warren LLP
Kelley Drye & Warren LLP
Article

California's Fall 2026 Privacy Roundup: Expanded CCPA Deletion Rights And More

California Governor Gavin Newsom has signed several significant privacy bills that will reshape how businesses handle consumer data, including expanded deletion rights under the CCPA, shortened data broker response cycles, and sweeping new insurance sector privacy requirements. While one landmark bill banning the sale of sensitive personal information was vetoed, the approved legislation requires companies to update their deletion workflows...
United StatesPrivacy
McDermott Will & Schulte
McDermott Will & Schulte
Article

The Data Breach Brief: Week Of September 30th, 2026

Multiple organizations have recently disclosed significant data breaches affecting thousands of individuals, with compromised information ranging from basic contact details to highly sensitive medical records and financial data. The incidents span various sectors including healthcare, insurance, and professional services, raising questions about the scope of exposure and potential remedies for affected individuals.
United StatesPrivacy
Morgan & Morgan
Morgan & Morgan
Article

Emerging Enforcement Trends In Digital Health Data Privacy: Lessons From Washington’s My Health My Data, FTC vs. Hims & Hers And UCHealth Enforcement Actions

Federal and state regulators are intensifying scrutiny of healthcare and digital health companies over tracking technologies that share sensitive patient data with advertising platforms. Recent enforcement actions against major telehealth providers and healthcare systems reveal how common marketing practices can trigger significant legal liability under privacy laws, even for organizations not covered by HIPAA.
United StatesPrivacy
Benesch, Friedlander, Coplan & Aronoff LLP
Benesch, Friedlander, Coplan & Aronoff LLP
Article

California Legislation: End-Of-Session Check-In

California's legislature has sent a comprehensive package of privacy, AI, and advertising bills to Governor Newsom's desk, with decisions due by September 30, 2026. The legislation addresses sensitive personal information protections, data broker obligations, AI-powered chatbot regulations, and digital replica rights, potentially reshaping how businesses handle consumer data and automated decision-making systems. Will these bills become law and set new national standards for technology regulation?
United StatesPrivacy
Frankfurt Kurnit Klein & Selz PC
Frankfurt Kurnit Klein & Selz PC
Article

FCC Replaces TCPA “Revoke All” Rule: New Category-Specific Opt-Out Rules For Robocalls And Robotexts

The Federal Communications Commission has fundamentally altered how businesses must handle consumer opt-out requests under the Telephone Consumer Protection Act, replacing the broad "revoke all" mandate with a more nuanced, category-specific approach for informational messages. This regulatory shift allows companies to maintain separate consent tracks for different types of non-marketing communications while preserving stricter opt-out requirements for telemarketing messages. The Updated Order introduces ne
United StatesConsumer Protection
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

Healthcare Trends & Transactions Q2 2026

Healthcare M&A activity maintained steady momentum through Q2 2026, driven by physician practice consolidation, AI-enabled technology acquisitions, and strategic outpatient expansion. Private equity investment persisted despite intensifying regulatory scrutiny of MSO arrangements, while digital health buyers paid significant premiums for platforms demonstrating production-grade AI capabilities and proprietary data assets.
United StatesCorporate/Commercial Law
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

DOJ Continues DEI False Claims Act Enforcement With $25 Million Accenture Settlement

The Department of Justice announced a $25 million settlement with Accenture Federal Services over allegations that the company violated the False Claims Act by falsely certifying compliance with anti-discrimination requirements while allegedly using race or sex in hiring, promotion, and access to professional development programs. This marks the third major DEI-related FCA enforcement action in 2026, following similar settlements with IBM and Deloitte.
United StatesGovernment, Public Sector
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

DOJ's $2 Million Honeywell Settlement Under The Civil Cyber-Fraud Initiative: What Compliance Failures Mean For Defense Contractors

The Department of Justice secured a $2 million settlement with Honeywell Aerospace for allegedly failing to comply with NIST SP 800-171 cybersecurity requirements under a Department of War contract. This case demonstrates how cybersecurity compliance failures can trigger False Claims Act liability even without an actual data breach or cyberattack, and highlights the growing role of whistleblowers in exposing contractors' gaps between contractual obligations and actual security practices.
United StatesGovernment, Public Sector
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

No More SEC Responses To Rule 14a-8 No-Action Requests: What Public Companies Should Know For The Upcoming Proxy Season

The SEC's Division of Corporation Finance has announced it will no longer respond to Rule 14a-8 no-action requests, marking a significant shift in the shareholder proposal process. Companies must still comply with notification requirements under Rule 14a-8(j), but without staff guidance on exclusion decisions, they will need to rely on existing SEC guidance, precedent, and judicial decisions.
United StatesCorporate/Commercial Law
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

CAS Board Raises Contract Thresholds To $35 Million And Eliminates CAS 407: What Federal Contractors Need To Know As DoW Demands Cost And Pricing Transparency

The CAS Board has raised contract thresholds to $35 million and eliminated CAS 407, fundamentally changing cost accounting requirements for federal contractors. At the same time, the Department of War is demanding unprecedented cost and pricing transparency through new memoranda requiring actual cost information for negotiations valued at $10 million or more, creating a complex landscape where contractors face fewer formal CAS requirements but heightened scrutiny of their pricing data.
United StatesAccounting and Audit
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

Still Tracking, Still Suing: Website Privacy Litigation After SB 690

California's SB 690 eliminates private lawsuits under CIPA for pen register and trap-and-trace device theories, but website tracking litigation continues under federal wiretapping statutes, ECPA's crime-tort exception, and sector-specific claims. Businesses face ongoing risk from cookies, pixels, and tracking technologies that may unlawfully intercept visitor communications or collect routing data without proper consent.
United StatesPrivacy
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

BIS Settlement Highlights Export Control Risks For Medical And Research Technology

The U.S. Department of Commerce's Bureau of Industry and Security reached a $1.7 million settlement with Plexon, Inc. over unlicensed exports of neural recording systems to a Chinese research institution on the Entity List. This enforcement action demonstrates that medical and research products are subject to U.S. export controls, and even EAR99 items may require licenses based on destination, end user, or end use.
United StatesInternational Law
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC